Jaclyn LoPiccolo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nelfinavir | 5 | 2021 | 68 | 1.160 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2017 | 74 | 0.670 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2018 | 249 | 0.570 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2019 | 300 | 0.520 |
Why?
|
| Prednisone | 1 | 2018 | 1574 | 0.460 |
Why?
|
| Sexual Dysfunctions, Psychological | 10 | 1986 | 187 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2017 | 2503 | 0.430 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 13102 | 0.380 |
Why?
|
| Protein Multimerization | 1 | 2015 | 970 | 0.370 |
Why?
|
| GTP-Binding Protein gamma Subunits | 2 | 2017 | 24 | 0.290 |
Why?
|
| GTP-Binding Protein beta Subunits | 2 | 2017 | 33 | 0.290 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2007 | 111 | 0.280 |
Why?
|
| Sexual Dysfunction, Physiological | 7 | 1991 | 360 | 0.240 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11524 | 0.230 |
Why?
|
| HIV Protease Inhibitors | 3 | 2014 | 430 | 0.230 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2023 | 104 | 0.210 |
Why?
|
| Smoke | 1 | 2024 | 227 | 0.210 |
Why?
|
| Metatarsophalangeal Joint | 1 | 2001 | 38 | 0.200 |
Why?
|
| Orgasm | 8 | 1986 | 64 | 0.200 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 1142 | 0.200 |
Why?
|
| Protein Kinases | 1 | 2007 | 1640 | 0.190 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 13695 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5686 | 0.180 |
Why?
|
| Chloroquine | 1 | 2021 | 280 | 0.170 |
Why?
|
| Pneumocystis carinii | 1 | 2018 | 74 | 0.150 |
Why?
|
| Pinocytosis | 1 | 2017 | 65 | 0.150 |
Why?
|
| Marital Therapy | 4 | 1986 | 45 | 0.150 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 237 | 0.140 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 768 | 0.140 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2015 | 30 | 0.130 |
Why?
|
| Penile Erection | 3 | 1992 | 97 | 0.130 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2015 | 50 | 0.130 |
Why?
|
| Apoptosis | 4 | 2021 | 9727 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 436 | 0.120 |
Why?
|
| Erectile Dysfunction | 5 | 1992 | 461 | 0.120 |
Why?
|
| Penis | 2 | 1992 | 216 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2938 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2018 | 3913 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3557 | 0.110 |
Why?
|
| Bronchoscopy | 1 | 2018 | 862 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8642 | 0.110 |
Why?
|
| Catalytic Domain | 1 | 2015 | 698 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 693 | 0.100 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 162 | 0.100 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 16689 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2012 | 209 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 124 | 0.100 |
Why?
|
| Ceramides | 1 | 2012 | 199 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 627 | 0.100 |
Why?
|
| Humans | 41 | 2024 | 744343 | 0.090 |
Why?
|
| Autophagy | 2 | 2007 | 1300 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.080 |
Why?
|
| Sexual Behavior | 10 | 1991 | 2057 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2012 | 791 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3846 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2017 | 23403 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5853 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10481 | 0.080 |
Why?
|
| Boronic Acids | 1 | 2012 | 965 | 0.080 |
Why?
|
| Marriage | 6 | 1985 | 339 | 0.070 |
Why?
|
| Smoking | 1 | 2024 | 8987 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1230 | 0.070 |
Why?
|
| Libido | 3 | 1985 | 121 | 0.070 |
Why?
|
| Genes, ras | 1 | 2009 | 690 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.070 |
Why?
|
| Psychotherapy, Multiple | 1 | 1985 | 7 | 0.070 |
Why?
|
| Neoplasms | 3 | 2014 | 21683 | 0.070 |
Why?
|
| Psychotherapy | 3 | 1985 | 1643 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5172 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1801 | 0.060 |
Why?
|
| Male | 24 | 2019 | 350118 | 0.060 |
Why?
|
| Liver | 1 | 2018 | 7474 | 0.050 |
Why?
|
| Counseling | 1 | 1991 | 1523 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4204 | 0.050 |
Why?
|
| Drug Design | 1 | 2007 | 1076 | 0.050 |
Why?
|
| Behavior Therapy | 3 | 1982 | 865 | 0.050 |
Why?
|
| Sex Education | 1 | 1982 | 93 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 1144 | 0.050 |
Why?
|
| Adult | 17 | 2018 | 214055 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 2025 | 0.050 |
Why?
|
| Masturbation | 3 | 1975 | 8 | 0.050 |
Why?
|
| Germ Cells | 1 | 2023 | 631 | 0.040 |
Why?
|
| Psychological Tests | 3 | 1979 | 651 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39050 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2007 | 2109 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20129 | 0.040 |
Why?
|
| Ejaculation | 3 | 1986 | 58 | 0.040 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 164 | 0.040 |
Why?
|
| Caspases | 2 | 2012 | 928 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 72290 | 0.040 |
Why?
|
| Female | 23 | 2024 | 380194 | 0.040 |
Why?
|
| Aged | 5 | 2019 | 163280 | 0.030 |
Why?
|
| Lipids | 1 | 2007 | 3305 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2219 | 0.030 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2015 | 30 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2012 | 3689 | 0.030 |
Why?
|
| Spodoptera | 1 | 2015 | 153 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 2988 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2015 | 25 | 0.030 |
Why?
|
| Animals | 9 | 2015 | 168757 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2017 | 331 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2015 | 87 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 2015 | 85 | 0.030 |
Why?
|
| Peptides | 1 | 2007 | 4409 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 1977 | 977 | 0.030 |
Why?
|
| Maryland | 1 | 2014 | 276 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 2382 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9386 | 0.030 |
Why?
|
| RNA Interference | 2 | 2012 | 2889 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 3505 | 0.030 |
Why?
|
| Middle Aged | 9 | 2019 | 213383 | 0.030 |
Why?
|
| Psychosexual Development | 1 | 1972 | 20 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2012 | 5221 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 892 | 0.030 |
Why?
|
| Social Values | 1 | 1973 | 224 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2012 | 54 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2012 | 91 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 7913 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3462 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 3701 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2012 | 286 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2023 | 3444 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 1992 | 281 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 390 | 0.020 |
Why?
|
| Arousal | 2 | 1986 | 1165 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 1973 | 481 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 12354 | 0.020 |
Why?
|
| Personality | 1 | 1972 | 552 | 0.020 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2007 | 10 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1792 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2916 | 0.020 |
Why?
|
| Virilism | 1 | 1966 | 31 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
| Norethindrone | 1 | 1966 | 59 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 63114 | 0.020 |
Why?
|
| Attitude | 3 | 1979 | 776 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6622 | 0.020 |
Why?
|
| Personal Satisfaction | 3 | 1985 | 643 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 29786 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1966 | 456 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1992 | 12959 | 0.010 |
Why?
|
| Mice | 4 | 2012 | 81183 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2023 | 12208 | 0.010 |
Why?
|
| Manuals as Topic | 1 | 1982 | 98 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 17446 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.010 |
Why?
|
| Sirolimus | 1 | 2009 | 1564 | 0.010 |
Why?
|
| Testis | 1 | 1985 | 803 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 1986 | 737 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1985 | 712 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2825 | 0.010 |
Why?
|
| Time Factors | 2 | 2014 | 40075 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6386 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9734 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 57776 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Coitus | 1 | 1975 | 133 | 0.010 |
Why?
|
| Cognition | 1 | 1972 | 6770 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1992 | 19905 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 5181 | 0.010 |
Why?
|
| Family | 1 | 1985 | 3147 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 10252 | 0.010 |
Why?
|
| Love | 1 | 1973 | 36 | 0.010 |
Why?
|
| Research | 1 | 1982 | 1999 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1975 | 1681 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1129 | 0.010 |
Why?
|
| MMPI | 1 | 1972 | 86 | 0.010 |
Why?
|
| Thematic Apperception Test | 1 | 1972 | 39 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 11031 | 0.010 |
Why?
|
| Role | 1 | 1972 | 175 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19229 | 0.010 |
Why?
|
| Homosexuality | 1 | 1972 | 262 | 0.010 |
Why?
|
| Fixation, Ocular | 1 | 1972 | 251 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18029 | 0.010 |
Why?
|
| Social Perception | 1 | 1973 | 425 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 56430 | 0.000 |
Why?
|
| Estrus | 1 | 1966 | 81 | 0.000 |
Why?
|
| Castration | 1 | 1966 | 159 | 0.000 |
Why?
|
| Self Concept | 1 | 1972 | 1025 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 29063 | 0.000 |
Why?
|
| Genitalia | 1 | 1966 | 112 | 0.000 |
Why?
|
| Pregnancy, Animal | 1 | 1966 | 134 | 0.000 |
Why?
|
| Interpersonal Relations | 1 | 1973 | 1425 | 0.000 |
Why?
|
| Psychometrics | 1 | 1974 | 3002 | 0.000 |
Why?
|
| Visual Perception | 1 | 1972 | 1420 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1984 | 382 | 0.000 |
Why?
|
| Uterus | 1 | 1966 | 711 | 0.000 |
Why?
|
| Ovary | 1 | 1966 | 981 | 0.000 |
Why?
|
| Emotions | 1 | 1973 | 2661 | 0.000 |
Why?
|
| Organ Size | 1 | 1966 | 2252 | 0.000 |
Why?
|
| Sex Factors | 2 | 1985 | 10397 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1966 | 2726 | 0.000 |
Why?
|
| Rats | 1 | 1966 | 24260 | 0.000 |
Why?
|
| Adolescent | 1 | 1973 | 85781 | 0.000 |
Why?
|
| Pregnancy | 1 | 1966 | 29144 | 0.000 |
Why?
|